Royal Philips (NYSE:PHG) reported quarterly earnings of €0.41 per share. This is a 28.07 percent decrease over earnings of €0.57 per share from the same period last year. The company reported €5.42 billion in sales this quarter. This is a 9.67 percent increase over sales of €4.94 billion in the same period last year.
Plus Therapeutics Reports Interim Updates from Two ReSPECT Clinical Trials at SNMMI Annual Meeting
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system
